This inventor holds 1 USPTO granted patent. Top assignee: Chengdu Sintanovo Biotechnology Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Haibo Zhou - Innovator in Polypeptide Compounds
Introduction
Haibo Zhou is a notable inventor based in Sichuan, China. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide compounds. His work focuses on creating pharmaceutical compositions that have the potential to improve clinical outcomes.
Latest Patents
Haibo Zhou holds a patent for a polypeptide compound, pharmaceutical composition, preparation method, and application thereof. The invention discloses a polypeptide compound that acts as a κ-opioid receptor agonist. This compound is noted for its enhanced activity and potential as a clinical candidate. The structural formula of the polypeptide compound is represented in general formula (I).
Career Highlights
Zhou is currently associated with Chengdu Sintanovo Biotechnology Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has garnered attention for its potential applications in medicine.
Collaborations
He collaborates with notable colleagues such as Jian Gao and Xiaoping Fu, contributing to a dynamic research environment that fosters innovation.
Conclusion
Haibo Zhou's contributions to the field of biotechnology, particularly through his patent on polypeptide compounds, highlight his role as an influential inventor. His work has the potential to impact clinical practices significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile